Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

News articleYahoo Finance· March 12, 2026

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance Rapid Micro Biosystems, Inc…

Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

Looking ahead, we expect our proven track record of consistent execution to further advance our strategic priorities of accelerating Growth Direct system placements, expanding gross margin, delivering new product innovation and prudently managing our cash
60% confidence
Our performance was highlighted by key commercial wins, including a record multi-system order from Amgen in the fourth quarter
60% confidence
For the full year 2026, the Company expects total revenue in the range of $37.0 million to $41.0 million including a range of 30 to 38 Growth Direct system placements and gross margin percentage of approximately 20%
60% confidence
We closed 2025 with significant momentum, delivering 20% year-over-year revenue growth
60% confidence
These milestones demonstrate the accelerating global adoption of the Growth Direct platform as our customers standardize on our technology across their manufacturing networks
60% confidence